Infections Due To Enterobacteriaceae clinical trials

Explore recruiting infections due to enterobacteriaceae clinical trials.

Recruiting infections due to enterobacteriaceae studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Infections Due To Enterobacteriaceae trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ):randomised, pragmatic trial

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Infections Due To Enterobacteriaceae trials by city

Infections Due To Enterobacteriaceae in Toronto Infections Due To Enterobacteriaceae in Vancouver Infections Due To Enterobacteriaceae in Montreal Infections Due To Enterobacteriaceae in Calgary Infections Due To Enterobacteriaceae in Edmonton Infections Due To Enterobacteriaceae in Ottawa Infections Due To Enterobacteriaceae in Winnipeg Infections Due To Enterobacteriaceae in Quebec City Infections Due To Enterobacteriaceae in Hamilton Infections Due To Enterobacteriaceae in Kitchener Infections Due To Enterobacteriaceae in London Infections Due To Enterobacteriaceae in Halifax Infections Due To Enterobacteriaceae in New York Infections Due To Enterobacteriaceae in Los Angeles Infections Due To Enterobacteriaceae in Chicago Infections Due To Enterobacteriaceae in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease